Green Planet Bioengineering Reports Q3 2025 Net Loss of $8,599 Amid Rising Administrative Expenses

Green Planet Bioengineering Co., Ltd. reported its financial results for the third quarter of 2025, revealing a net loss of $8,599 for the three months ending September 30, compared to a loss of $5,425 during the same period in 2024. For the nine months ended September 30, 2025, the company recorded a net loss of $19,544, a decrease from the $22,753 loss reported in the prior year. The increase in losses is attributed primarily to higher administrative expenses, which rose to $8,599 in Q3 2025 from $5,425 in Q3 2024, reflecting ongoing operational costs despite the absence of active business operations.

The company’s balance sheet as of September 30, 2025, shows total current liabilities of $484,678, up from $465,134 at the end of 2024. This increase is largely due to amounts due to a related party, which rose to $479,148 from $459,634. Green Planet Bioengineering continues to operate as a public reorganized shell corporation, with no active business operations, relying on financial support from a related party to cover its expenses. The company has not issued any new shares of common or preferred stock during the reporting period, maintaining a consistent share count of 20,006,402.

Operationally, the company has not reported any significant changes in customer counts or product adoption rates, as it remains focused on identifying potential business opportunities for future growth. The lack of active operations has resulted in no new product launches or geographic expansions. The company’s employee headcount remains unchanged, reflecting its current status as a shell corporation without ongoing business activities.

Looking ahead, Green Planet Bioengineering's ability to continue as a going concern is contingent upon securing adequate funding and identifying profitable business opportunities. The company has expressed that its future operations will depend on the prevailing circumstances and the continued support from its majority stockholder. Management has indicated that while they are optimistic about future prospects, there are no guarantees regarding the timing or success of potential business ventures. The financial statements underscore the uncertainty surrounding the company's future, emphasizing the need for ongoing financial support to sustain operations.